long-term results of zuma-1 trial for patients with nhl
Published 6 years ago • 121 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
2:02
discussing the results from the zuma-1 trial for patients with advanced lymphoma
-
1:50
dr. locke discusses long-term follow-up of zuma-1 trial for nhl
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
4:52
long term follow up on the zuma-1 trial for nhl
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
0:53
design of the zuma-1 trial in non-hodgkin lymphoma
-
1:16:35
bi-and tri-specific antibodies in non-hodgkin lymphoma: current data and perspectives
-
1:07:42
dtct lecture 1 (dr. prashant mehta )
-
49:29
hodgkin lymphoma | rebekah needer, lymphoma care nurse
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
0:46
key takeaway from 2-year follow-up data of zuma-1 trial in large b-cell lymphoma
-
3:58
zuma-1: a pivotal trial of car t-cells in nhl
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
5:50
large b-cell lymphoma: zuma-1 trial
-
2:00
zuma-1 trial: fda approval and follow-up of car t-cell product axicabtagene ciloleucel
-
0:43
safety findings for axi-cel in patients with dlbcl
-
6:03
clinical data for axi-cel in lymphoma
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
1:34
zuma-1 update: safety data of axi-cel in patients with r/r dlbcl